Abstract

Objective To observe the effect of intestinal peptide on cell migration and invasion of the DU145 cells, and explore the mechanism of epithelial-mesenchymal transition. Methods DU145 cells were treated with VIP at concentrations of 0, 25, 50 and 100 μmol/L, respectively. E-cadherin, Vimentin, and Snail mRNA and protein were detected by reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blotting respectively at 24 h. The cell mobility, migration and invasion ability of DU145 cells were respectively measured by wound-healing assay, Transwell migration and invasion assays at 48 h. Results With the increases of concentrations of VIP for 24 h, the expression levels of E-cadherin, Vimentin, and Snail mRNA in PC-3 cells were increased at 24 h (0.897±0.053, 0.715±0.041, 0.521±0.036, 0.343±0.029; 0.586±0.061, 0.827±0.089, 1.329±0.107, 1.764±0.135; 0.645±0.055, 0.917±0.074, 1.383±0.097, 1.725±0.124; P<0.05). Meanwhile, the cell mobility was increased, the number of migrative cells and invasive cells was significantly increased gradually with the increased concentrations of VIP [(76.7±5.8), (104.5±6.7), (128.3±10.4), (147.7±12.6) cells; (84.2±6.4), (118.3±10.3), (142.1±13.7), (173.6±15.4) cells; P<0.01]. Conclusion VIP can increase ability of movement, migration and invasion of prostate cancer DU145 cells by epithelial-mesenchymal transition. Key words: Vasoactive intestinal peptide; Prostate carcinoma; Tumor metastasis; Epithelial-mesenchymal transition

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.